DHA and cognitive function in the elderly: A systematic review of the literature

Research and Practice in Alzheimer's Disease

Volumn 11, Issue , 2006, Pages 381-387

  Noel, K ^a   Hoffman, J ^b   Ellis, L ^b   Yurko Mauro, K ^b   Cella, C ^a   Sercus, B ^a   Nalysnyk, L ^a  

^a MetaWorks Inc   (United States)

^b Martek Biosciences Corporation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOCOSAHEXAENOIC ACID; GINKGO BILOBA EXTRACT; GOTU KOLA EXTRACT; ICOSAPENTAENOIC ACID; PLACEBO; PLANT EXTRACT; UNCLASSIFIED DRUG;

AGING; ALZHEIMER DISEASE; AUTOPSY; BRAIN TISSUE; CLINICAL TRIAL; COGNITION; COGNITIVE DEFECT; DEMENTIA; DRUG BRAIN LEVEL; EVIDENCE BASED MEDICINE; GERIATRIC PATIENT; GOTU KOLA; HUMAN; MEDICINAL PLANT; MENTAL PERFORMANCE; META ANALYSIS; REVIEW; SYSTEMATIC REVIEW;

EID: 33847010932     PISSN: 12848360     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Review

References (27)

1. Anderson P, Green S, Higgins JPT (Eds) Cochrane Collaboration Handbook 4.2.1 [updated December 2003]. In: The Cochrane Library, Issue 1. John Wiley & Sons; Chichester UK; 2004.
2. Ma YX, Zhao SM, Chen SY, Wang ZS, Shen MH: The effect of "Germanium-132 + DHA + EPA" on the cognitive impairment and blood rheology in the preaged and aged. Naunyn Schmiedebergs Arch Pharmacol 1998; 358:P5163 (abstract).
3. Miyanaga K, Yonemura K, Ishikawa C, Yazawa K: The effect of DHA on demented disease. Neurobiol Aging 1996; 17 Suppl 4S:S73 (abstract 290).
4. Suzuki H, Morikawa Y, Takahasi H: Effect of DHA oil supplementation on intelligence and visual acuity in the elderly. World Rev Nutr Diet 2001; 88:68-71.
5. Terano T, Fujishiro S, Ban T, et al: Docosahexaenoic acid supplementation improves the moderately severe dementia from thrombotic cerebrovascular diseases. Lipids 1999; 34 Suppl:S345-346.
6. Heude B, Ducimetiere P, Berr C: Cognitive decline and fatty acid composition of erythrocyte membranes. The EVA Study. Am J Clin Nutr 2003; 77:803-808.
7. Schaefer EJ: Plasma phosphatidylcholine (PC) docosahexaenoic acid (DHA), fish intake and risk of dementia in the Framingham Heart Study. Atherosclerosis 2003; Suppl 4L15 (abstract IWS04-1).
8. Conquer JA, Tierney MC, Zecevic J, Bettger WJ, Fisher RH: Fatty acid analysis of blood plasma of patients with Alzheimer's disease, other types of dementia, and cognitive impairment. Lipids 2000; 35:1305-1312.
9. Corrigan FM, van Rhijn AG, Ijomah G, et al: Tin and fatty acids in dementia. Prostaglandins Leukot Essent Fatty Acids 1991; 43:229-238.
10. McGrath LT, Foy CJ, Stockman A, Lawson JT, Passmore AP: Oleic acid content of red cell membranes in Alzheimer's disease and vascular dementia. Alzheimer Reports 1999; 2:209-212.
11. Tully AM, Roche HM, Doyle R, et al: Low serum cholesteryl ester docosahexaenoic acid levels in Alzheimer's disease: A case-control study. Br J Nutr 2003; 89:483-489.
12. Boston PF, Bennett A, Horrobin DF, Bennett CN: Ethyl-EPA in Alzheimer's disease - A pilot study. Prostaglandins Leukot Essent Fatty Acids 2004; 71:341-346.
13. Barberger-Gateau P, Letenneur L, Deschamps V, et al: Fish, meat and risk of dementia: Cohort study. Br Med J 2002; 325:932-933.
14. Englehart MJ, Geerlings MI, Ruitenberg A, et al: Diet and risk of dementia: Does fat matter? The Rotterdam Study. Neurology 2002; 59:1915-1921.
15. Kalmijn S, Launer LJ, Ott A, et al: Dietary fat intake and the risk of incident dementia in the Rotterdam Study. Ann Neurol 1997; 42:776-82.
16. Kalmijn S, Fsekens EJM, Launer LJ, et al: Polyunsaturated fatty acids, antioxidants, and cognitive function in very old men. Am J Epidemiol 1997; 145:33-41.
17. Kalmijn S, van Boxtel MPJ, Ocke M, et al: Dietary intake of fatty acid and fish in relation to cognitive performance at middle age. Neurology 2004; 62:275-280.
18. Morris MC, Evans DA, Bienias JL, et al: Consumption of fish and n-3 fatty acids and risk of incident Alzheimer's disease. Arch Neurol 2003; 60:940-946.
19. Calon F, Lim GP, Yang F, et al: Docosahexaenoic acid protects from dendritic pathology in an Alzheimer's disease mouse model. Neuron 2004; 43:633-645.
20. Hosokawa M, Umezawa M, Chakroborty B, Higuchi K: Dietary lipids and proteins influence learning and memory in the SAMP8 strain of mice. Report of the Soy Protein Research Committee (Japan) 1996; 17:89-93.
21. Hung M-C, Shibasaki K, Yoshida R, Sato M, Imaizumi K: Learning behavior and cerebral protein kinase C, antioxidant status, lipid composition in senescence-accelerated mouse: Influence of a phosphatidylcholine-vitamin B12 diet. Br J Nutr 2001; 86:163-171.
22. Lim GP, Calon F, Morihara T, et al: A diet enriched with the omega-3 fatty acid docosahexaenoic acid reduces amyloid burden in an aged Alzheimer mouse model. J Neurosci 2005; 25:3032-3040.
23. Suganami H, Ikeo T: Amelioration of learning impairment by docosahexaenoic acid in SAMP8 mice. Shika Igaku 1995; 58:435-446.
24. Umezawa M, Ohta A, Tojo H, et al: Dietary a-linoleate/linoleate balance influences learning and memory in the senescence-accelerated mouse (SAM). Brain Res 1995; 669:225-233.
25. Carlson JJ, Farquhar JW: The effect of a supplement containing Gingko biloba, fish oil and Gotu kola on cognitive function and quality of life in older healthy adults. Am J Clin Nutr 2002; 75(2 Suppl): 438S (abstract # 317).
26. Laurin D, Verreault R, Lindsay J, Dewailly E, Holub BJ: Omega-3 fatty acids and risk of cognitive impairment and dementia. J Alzheimer Dis 2003; 5:315-322.
27. MacLean CH, Issa AM, Newberry SJ, et al: Effects of Omega-3 Fatty Acids on Cognitive Function with Aging, Dementia, and Neurological Diseases. Summary, Evidence Report/Technology Assessment No.114. (Prepared by the Southern California Evidence-based Practice Center under Contract No. 290-02-0003.) AHRQ Publication No. 05-E011-1 & 2. Rockville, MD: Agency for Healthcare Research and Quality. February 2005.